SEIJI ONITSUKA

Dr. SEIJI ONITSUKA

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
YOYukihisa Ogawa
Yukihisa Ogawa
NFNaoki Fujimura
Naoki Fujimura
MYMasato Yamaguchi
Masato Yamaguchi
HBHiroshi Banno
Hiroshi Banno
TFTadashi Furuyama
Tadashi Furuyama
SIShigeo Ichihashi
Shigeo Ichihashi
Purpose: To evaluate the clinical utility of the Gore Excluder iliac branch endoprosthesis (IBE) for Japanese patients with aortoiliac aneurysms. Materials and Methods: This was a multicenter retrospective cohort study (J-Preserve Registry). Patients undergoing endovascular aortic repair using the Gore Excluder IBE for aortoiliac aneurysms between August 2017 and June 2020 were enrolled. Data pertaining to the baseline and anatomical characteristics, technical details, and clinical outcomes were collected from each institution. The primary endpoints were technical success, IBE-related complications, and reinterventions. Secondary endpoints were mortality, aneurysm size change, and reintervention during follow-up. Technical success was defined as accurate deployment of the IBE without type Ib, Ic, or III endoleaks on the IBE sides on completion angiography. A change in aneurysm size of 5 mm or more was taken to be a significant change. Results: We included 141 patients with 151 IBE implantations. Sixty-five IBE implantations (43.0%) had at least one instruction for use violation. Twenty-two patients (15.6%) required internal iliac artery (IIA) embolization for external iliac artery extension on the contralateral side. Of 151 IBE implantations, 19 exhibited IIA branch landing zones due to IIA aneurysms. Mean maximum and proximal common iliac artery (CIA) diameters were 32.9±9.9 mm and 20.5±6.9 mm, respectively. The mean CIA length was 59.1±17.1 mm. The IIA landing diameter and length were 9.0±2.3 mm and 33.8±14.6 mm. The overall technical success rate was 96.7%. There were no significant differences in IBE-related complications (2.3% vs 5.3%, p=0.86) or IBE-related reinterventions (1.5% vs 5.3%, p=0.33) between the IIA trunk and IIA branch landing groups. The mean follow-up period was 635±341 days. The all-cause mortality rate was 5.0%. There were no aneurysm-related deaths or ruptures during the follow-up. Most patients (95.7%) had sac stability or shrinkage. Conclusion: The Gore Excluder IBE was safe and effective for Japanese patients in the midterm. Extending the IIA device into the distal branches of the IIA was acceptable, which may permit extending indications for endovascular aortic aneurysm repair of aortoiliac aneurysms to more complex lesions. Clinical Impact: This study suggests clinical benefits of the Gore Excluder IBE for Japanese patients, despite 43% of the IBE implantations having at least one IFU violation.

25 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SOSEIJI ONITSUKA
SEIJI ONITSUKA
ATAtsuhisa Tanaka
Atsuhisa Tanaka
HOHiroyuki Otsuka
Hiroyuki Otsuka
YSYusuke Shintani
Yusuke Shintani
RKRyo Kanamoto
Ryo Kanamoto
ETEiki Tayama
Eiki Tayama
Endovascular stent graft repair was developed to minimize the invasiveness of open surgery for thoracic and abdominal aortic diseases. This approach involves covering the diseased segment with a stented artificial graft. However, in thoracic endovascular aortic repair (TEVAR) for aortic arch diseases, special consideration is needed to preserve the aortic arch vessels. Standard stent grafts often require additional procedures, such as bypass surgery, to reconstruct the arch vessels. The semi-custom-made Najuta fenestrated stent graft was developed to address this issue. It is a three-dimensional patient-specific stent graft with fenestrations that allow for the preservation of the arch vessels. This study discusses the unique features of the Najuta stent graft and the techniques for its deployment, and it provides an analysis of treatment outcomes based on the current literature.

25 March 2023 in Annals of Vascular Diseases
Verified
Journal Article
Open access
PDF file
SOSEIJI ONITSUKA
SEIJI ONITSUKA
HIHiroyuki Ito
Hiroyuki Ito
An aneurysm sac enlargement caused by type II endoleak (T2EL) following endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms may cause serious complications such as rupture. Consequently, methods that preoperatively prevent or postoperatively treat T2EL have been employed. When significant aneurysm enlargement occurs due to persistent T2EL, embolization is first performed through several access points. However, although these endovascular reinterventions have a high technical success rate and are safe, their effectiveness remains questionable. When such endovascular procedures fail to stabilize sac enlargement, open surgical conversion (OSC) becomes the last-resort treatment option. We review several strategies of OSC for the repair of T2EL following EVAR. Among the three main OSC procedures, namely, complete endograft removal, partial endograft removal, and complete endograft preservation, partial endograft removal under infrarenal clamping was considered the most appropriate owing to its less invasiveness and durability.

6 March 2022 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
NFNaoki Fujimura
Naoki Fujimura
SIShigeo Ichihashi
Shigeo Ichihashi
HOHideaki Obara
Hideaki Obara
TAToshihisa Asakura
Toshihisa Asakura
MKMasatoshi Komooka
Masatoshi Komooka
TOTakao Ohki
Takao Ohki
Purpose: This study retrospectively evaluated the 12-month outcomes of the Zenith Alpha Abdominal Endovascular graft (Zenith Alpha AAA, Cook, Inc, Bloomington, Indiana), which was launched partially in Japan in March 2019, starting with 9 selected sites. Methods: A retrospective analysis was performed of all endovascular aneurysm repairs (EVAR) for abdominal aortic aneurysms using the Zenith Alpha AAA. Late complications were defined as any aneurysm-related events occurring >30 days after EVAR, including an aneurysm sac enlargement of >5 mm and any reinterventions performed. Endoleaks without sac enlargement or reinterventions were excluded from late complications. Results: During the study period, 79 EVARs using the Zenith Alpha AAA were performed. The mean age was 76.6±6.9 years old, 91.1% of patients were male, and the mean aneurysm diameter was 51.1±7.5 mm. Instructions for use violation was observed in 27 patients (34.2%), most frequently being a severely angulated proximal neck (>60°). There were 4 intraoperative complications, including 2 unintentional partial renal artery coverages caused by the premature anchoring of the exposed suprarenal stent barb to the aortic wall, which was a result of the design change of the top cap deletion. Since it was a partial coverage without flow impairment and since renal stenting was unsuccessful, it was left untreated and had no subsequent renal function impairment. During the mean follow-up of 444±123 days, 74 patients completed 12 months of follow-up. Freedom from late complications at 12 months was 90.8%, which included 2 limb occlusions (2.5%). Of 71 patients with a 12-month computed tomography scan, there was only 1 type 1a endoleak (1.3%), 1 sac enlargement of >5 mm (1.3%), and an aneurysm sac shrinkage of >5 mm was observed in 42.2% of patients. There was no type 3 endoleak during the follow-up. Conclusions: This study demonstrated that the new generation of low-profile Zenith Alpha AAA has satisfactory early clinical outcomes, comparable to those obtained with the conventional Zenith endovascular graft. Long-term follow-up is needed to determine whether these favorable outcomes persist.

3 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SOSEIJI ONITSUKA
SEIJI ONITSUKA
ATAtsuhisa Tanaka
Atsuhisa Tanaka
HOHiroyuki Otsuka
Hiroyuki Otsuka
YSYusuke Shintani
Yusuke Shintani
RKRyo Kanamoto
Ryo Kanamoto
ETEiki Tayama
Eiki Tayama
Endovascular stent graft repair was developed to minimize the invasiveness of open surgery for thoracic and abdominal aortic diseases. This approach involves covering the diseased segment with a stented artificial graft. However, in thoracic endovascular aortic repair (TEVAR) for aortic arch diseases, special consideration is needed to preserve the aortic arch vessels. Traditional stent grafts often require additional procedures, such as bypass surgery, to reconstruct the arch vessels. The semi-custom-made Najuta fenestrated stent graft was developed to address this issue. It is a three-dimensional patient-specific stent graft with fenestrations that allow for the preservation of the arch vessels. This study discusses the unique features of the Najuta stent graft and the techniques for its deployment and provides an analysis of treatment outcomes based on the current literature.